BioCentury
ARTICLE | Financial News

HGSI proposes follow-on

October 19, 2000 7:00 AM UTC

HGSI, a developer of gene-based drugs, proposed a follow-on offering of 8 million shares under its September $1 billion shelf registration (see BioCentury, Sept. 11). The offering, which has a 1.2 mi...